| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-2478(01)00267-X |
| P698 | PubMed publication ID | 11595291 |
| P50 | author | Nesrina Imami | Q41630663 |
| P2093 | author name string | F Gotch | |
| R Moss | |||
| B Gazzard | |||
| C Burton | |||
| G Hardy | |||
| A Pires | |||
| J Pido-Lopez | |||
| P2860 | cites work | Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA | Q56930699 |
| Immune control of HIV-1 after early treatment of acute infection | Q56961920 | ||
| Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy | Q57384728 | ||
| Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals | Q57997850 | ||
| Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans | Q59046097 | ||
| Changes in thymic function with age and during the treatment of HIV infection | Q59066353 | ||
| Inhibition of alloreactivity by mAb MR6: differential effects on IL-2- and IL-4-producing human T cells | Q61767365 | ||
| Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition | Q69383880 | ||
| Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) | Q71608623 | ||
| A simple method for the measurement of sjTREC levels in blood | Q73409321 | ||
| Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease | Q73470103 | ||
| Viral immune evasion due to persistence of activated T cells without effector function | Q24646943 | ||
| HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors | Q24676982 | ||
| Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Decay characteristics of HIV-1-infected compartments during combination therapy | Q29619375 | ||
| Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues | Q33652519 | ||
| Therapeutic vaccines in HIV.1 infection | Q33776160 | ||
| Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection | Q33817504 | ||
| The prime-boost strategy: exciting prospects for improved vaccination | Q33876983 | ||
| The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection | Q33904114 | ||
| Glucocorticoids in T cell development and function*. | Q33932702 | ||
| Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy | Q33932746 | ||
| A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team | Q34438252 | ||
| Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging | Q34581195 | ||
| Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes | Q35110576 | ||
| HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function | Q35834664 | ||
| Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics | Q36364647 | ||
| Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. | Q36623371 | ||
| CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection | Q36637922 | ||
| Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection | Q36889122 | ||
| A TH1-->TH2 switch is a critical step in the etiology of HIV infection | Q40709038 | ||
| K21-antigen: a molecule shared by the microenvironments of the human thymus and germinal centers | Q41013630 | ||
| Human Immunodeficiency Virus Type 1 Infection of CD4+ T Cells Down-Regulates the Expression of CD28: Effect on T Cell Activation and Cytokine Production | Q41267179 | ||
| Rapid effector function in CD8+ memory T cells | Q41847748 | ||
| The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses | Q41870329 | ||
| Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor | Q43502245 | ||
| Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease | Q43582240 | ||
| Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection | Q44519261 | ||
| Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection | Q44902494 | ||
| Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease | Q45740979 | ||
| Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors | Q45741753 | ||
| Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection | Q45745482 | ||
| Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen | Q45747985 | ||
| Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy | Q45760702 | ||
| In vivo migration and function of transferred HIV-1-specific cytotoxic T cells | Q47995100 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 63-76 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | immunology Letters | Q15766068 |
| P1476 | title | Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination | |
| P478 | volume | 79 |
| Q34344555 | A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection |
| Q44665386 | A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy |
| Q34169863 | Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010 |
| Q34355633 | Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs |
| Q37037090 | Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up. |
| Q57080548 | HIV-1-Specific CD4+ T Cell Responses in Chronically HIV-1 Infected Blippers on Antiretroviral Therapy in Relation to Viral Replication Following Treatment Interruption |
| Q78342521 | HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors |
| Q90740831 | Human labour is associated with altered regulatory T cell function and maternal immune activation |
| Q84049101 | Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects |
| Q38086432 | Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses |
| Q24815428 | Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy |
| Q55436453 | Progesterone Modulation of Pregnancy-Related Immune Responses. |
| Q45382246 | Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals |
| Q34609562 | Prospects for immune reconstitution in HIV-1 infection |
| Q45723089 | Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy |
| Q34801866 | STI and beyond: the prospects of boosting anti-HIV immune responses |
| Q33443913 | Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllers |
Search more.